FR2263756B1 - - Google Patents

Info

Publication number
FR2263756B1
FR2263756B1 FR757507898A FR7507898A FR2263756B1 FR 2263756 B1 FR2263756 B1 FR 2263756B1 FR 757507898 A FR757507898 A FR 757507898A FR 7507898 A FR7507898 A FR 7507898A FR 2263756 B1 FR2263756 B1 FR 2263756B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR757507898A
Other versions
FR2263756A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2263756A1 publication Critical patent/FR2263756A1/fr
Application granted granted Critical
Publication of FR2263756B1 publication Critical patent/FR2263756B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR757507898A 1974-03-14 1975-03-13 Expired FR2263756B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49028544A JPS5823393B2 (ja) 1974-03-14 1974-03-14 プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ

Publications (2)

Publication Number Publication Date
FR2263756A1 FR2263756A1 (fr) 1975-10-10
FR2263756B1 true FR2263756B1 (fr) 1979-02-09

Family

ID=12251592

Family Applications (1)

Application Number Title Priority Date Filing Date
FR757507898A Expired FR2263756B1 (fr) 1974-03-14 1975-03-13

Country Status (5)

Country Link
US (1) US4045468A (fr)
JP (1) JPS5823393B2 (fr)
DE (1) DE2510818C2 (fr)
FR (1) FR2263756B1 (fr)
GB (1) GB1484210A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517562A (en) * 1975-06-13 1978-07-12 Ici Ltd Prostane derivatives
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
US4178461A (en) * 1975-07-02 1979-12-11 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
US4180675A (en) * 1975-07-17 1979-12-25 Warner-Lambert Company 15-Cycloalkyl-prostaglandin derivatives
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
JPS6022708B2 (ja) * 1977-07-14 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
US4217346A (en) * 1978-06-05 1980-08-12 Sterling Drug Inc. Arylalkyl and aryloxyalkyl phosphonates as antiviral agents
GR77976B (fr) * 1982-03-12 1984-09-25 Schering Ag

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (fr) * 1971-04-30 1973-09-05
IL50310A (en) * 1972-11-08 1977-08-31 Pfizer Dimethyl ketophosphonates

Also Published As

Publication number Publication date
US4045468A (en) 1977-08-30
JPS50123647A (fr) 1975-09-29
FR2263756A1 (fr) 1975-10-10
DE2510818A1 (de) 1975-09-18
JPS5823393B2 (ja) 1983-05-14
DE2510818C2 (de) 1983-11-17
GB1484210A (en) 1977-09-01

Similar Documents

Publication Publication Date Title
AU495920B2 (fr)
AU7138274A (fr)
AU7099174A (fr)
BG20443A1 (fr)
AU479725A (fr)
AU481082A (fr)
AU481101A (fr)
AU481340A (fr)
AU481457A (fr)
AU481580A (fr)
AU482019A (fr)
AU482110A (fr)
AU482332A (fr)
AU480580A (fr)
AU480469A (fr)
BG20650A1 (fr)
BG19607A1 (fr)
BG19772A1 (fr)
BG19828A1 (fr)
BG22203A1 (fr)
BG19954A1 (fr)
BG19982A1 (fr)
BG20001A1 (fr)
BG20159A1 (fr)
BG22484A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse